About this trial
This observational study will determine the prevalence of underprescription in a cohort of elderly patients, recruited at the time of an outpatient geriatric visit, or hospitalized, upon admission to a geriatric ward.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Geriatric ward admission or outpatient geriatric appointment
Capacity to provide informed consent by the patient or legal guardian
Disqualifiers
Limited life expectancy as measured by the Clinical Frailty Scale (CFS) >8
Trial population
Older patients at admission to a geriatric ward or at the time of outpatient geriatric visits
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Rate of potential prescription omissions (PPOs)
Prevalence of potential prescription omissions (PPOs) will be evaluated by Screening Tool to Alert doctors to Right Treatment (START) criteria version 3 in aged patients enrolled on admission to geriatric departments of participating centers or during geriatric outpatient clinic visits
Secondary outcomes
Characterisation of the potential prescription omissions (PPOs)
The reasons for underprescription will be investigated to differentiate between justified and inappropriate potential prescriptive omissions (PPOs). Patients and/or their family members and/or the general practitioner will be interviewed to assess the potential reasons related to underprescription.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.